Ayelen Inda | Neuroscience | Young Scientist Award Posted on 21/06/2024 by sciencefatherLeave a Comment on Ayelen Inda | Neuroscience | Young Scientist Award Mrs. Ayelen Inda | Neuroscience | Young Scientist Award Pharmaceutical and Ph.D. in Chemical Sciences at Pharmaceutical Technology Research and Development Unit (UNITEFA), Argentina. Ayelen Inda is a dedicated researcher in pharmaceutical sciences, currently pursuing her Ph.D. in Chemical Sciences at the National University of Córdoba, Argentina. Her research focuses on innovative drug formulations aimed at addressing neurodegenerative diseases, particularly exploring the neuroprotective effects of bioactive compounds. Ayelen completed her undergraduate studies at the Faculty of Chemical Sciences, National University of Córdoba, where she achieved academic excellence. She has authored several impactful research papers published in renowned scientific journals, highlighting her contributions to pharmaceutical research. Ayelen has received prestigious awards and scholarships, including a CONICET Doctoral Scholarship, in recognition of her academic achievements and research potential. She actively participates in conferences and teaching activities, contributing to the dissemination of pharmaceutical knowledge and fostering scientific inquiry. Professional Profiles: Scopus Profile Education Ayelen Inda has pursued a dedicated academic journey focused on pharmaceutical sciences at the National University of Córdoba, Argentina. She completed her undergraduate studies from the Faculty of Chemical Sciences, achieving noteworthy academic performance with an average GPA of 7.00 without postponements. Subsequently, Ayelen embarked on her Ph.D. in Chemical Sciences, commencing in 2019 under the guidance of Dr. Daniela Alejandra Quinteros at the National University of Córdoba. Her doctoral research centers on investigating the potential neuroprotective effects of innovative pharmaceutical formulations containing new derivatives of bioactive molecules. This cooperative thesis also involves collaboration with the Academic Pedagogical Institute of Basic and Applied Sciences at the National University of Villa María, where Dr. Soledad Ravetti serves as co-director. Ayelen’s academic journey reflects her commitment to advancing pharmaceutical research and contributing to the field’s understanding of neuroprotection and innovative drug delivery systems. Professional Experience Ayelen Inda has amassed valuable professional experience, primarily centered around pharmaceutical technology and research. Currently affiliated with the Pharmaceutical Technology Research and Development Unit (UNITEFA) at the National University of Córdoba, Argentina, she plays a pivotal role in advancing innovative pharmaceutical formulations. Her expertise spans various facets of pharmaceutical sciences, including the development of novel drug delivery systems and the application of nanotechnology in pharmaceuticals. Ayelen has contributed significantly to research projects aimed at enhancing therapeutic strategies for neurodegenerative diseases and ocular disorders. Her work is underscored by a commitment to scientific inquiry and the application of advanced methodologies to address critical healthcare challenges. Research Interest Ayelen Inda’s research interests revolve around advancing pharmaceutical sciences through innovative drug delivery systems and nanotechnology applications. Her focus includes exploring the neuroprotective effects of bioactive compounds, particularly in treating neurodegenerative diseases and ocular disorders. Ayelen is also dedicated to optimizing pharmaceutical formulations to improve drug stability, bioavailability, and targeted delivery mechanisms. Her interdisciplinary approach integrates chemistry, pharmacology, and nanoscience to address challenges in drug development, aiming to enhance therapeutic efficacy and patient care. She actively contributes to scientific discourse through publications and presentations, aiming to translate research findings into practical applications that benefit healthcare and biomedical fields. Award and Honors Ayelen Inda has garnered prestigious awards and grants, underscoring her significant contributions to pharmaceutical research. Notably, she received the CONICET Doctoral Scholarship in 2019, focusing on innovative pharmaceutical formulations for neuroprotection. Her work was further recognized with the Roche Collaborative Research Fellowship, exploring antioxidants in pharmaceuticals. Government grants from the Ministry of Science and Technology (MINCYT) supported her research on ophthalmic inserts and antimicrobial nanoparticles. Additionally, she secured funding from the National University of Villa María for hybrid nanogels in cancer treatment and from the Ministry of Science and Technology of Córdoba for enhancing curcumin’s bioavailability. These accolades reflect Ayelen’s dedication to advancing pharmacological sciences through novel drug delivery systems and neuroprotective therapies, positioning her as a promising researcher in her field. Research Skills Ayelen Inda possesses robust research skills across various domains of pharmaceutical sciences. Her expertise includes experimental design, data analysis, and interpretation, particularly in the context of developing innovative drug delivery systems and studying the neuroprotective effects of bioactive compounds. Ayelen is adept at conducting in vitro and in vivo studies, utilizing techniques such as RP-HPLC for drug quantification and characterization. She demonstrates proficiency in nanotechnology applications, including the formulation of nanoparticles for targeted drug delivery. Her research skills extend to evaluating pharmacokinetics, pharmacodynamics, and toxicity profiles of novel formulations, essential for assessing their therapeutic efficacy and safety. Ayelen’s ability to integrate diverse scientific methodologies and her meticulous approach to research contribute significantly to advancing pharmaceutical sciences, particularly in developing new treatments for neurodegenerative diseases and enhancing drug delivery systems’ effectiveness. Her work underscores a commitment to rigorous scientific inquiry and innovation in pharmaceutical research. Publications Evidence of the protective role of Carvacrol in a retinal degeneration animal model Authors: Ayelen Inda, Martinez S, Bessone C, Ravetti S, Quinteros D Journal: Experimental Eye Research, 2024 Volume: 244 DOI: This link is disabled. New RP-HPLC method for the simultaneous determination of process yield and percentage of encapsulation of Gallein in albumin nanoparticles Authors: Ayelen Inda, Tettamanti CS, Martinez SM, Allemandi DA, Quinteros DA Journal: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2024 Volume: 1240 DOI: This link is disabled. Bi-coloured enhanced luminescence imaging by targeted switch on/off laser MEF coupling for synthetic biosensing of nanostructured human serum albumin Authors: Palacios LRG, Martinez SM, Tettamanti CS, Quinteros DA, Bracamonte AG Journal: Photochemical and Photobiological Sciences, 2023 Volume: 22(12) Pages: 2735–2758 DOI: This link is disabled. Citations: 1 Development of melatonin-loaded, human-serum-albumin nanoparticles formulations using different methods of preparation for ophthalmic administration Authors: Mickaela Martinez S, Ayelen Inda, Marina Garcia A, Alberto Allemandi D, Alejandra Quinteros D Journal: International Journal of Pharmaceutics, 2022 Volume: 628 DOI: This link is disabled. Citations: 8